Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing clinical study of interferon alpha-n1 in chronic myeloid leukemia
jRCT1080220037Phase 4
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Sep 2005
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of interferon alfa-n1 in chronic myelogenous leukemia (CML), sponsored by Otsuka Pharmaceutical Co., Ltd.
02
Drugs
interferon alfa-n1
03
Conditions
chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on jRCT1080220037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080220037.